DJIA 18,135.72 38.82 0.21%
NASDAQ 4,982.81 0.00 0.00%
S&P 500 2,101.04 2.51 0.12%
market minute promo

Medivation, Inc. (NASDAQ: MDVN)

company name or ticker

5 Biotech Stocks to Buy for 2015

These five biotech stocks may have what it takes to reward investors next year.

This Could Be the Next Big Pharma Buyout

Three Motley Fool analysts tell investors which three companies they think would be ripe for an acquisition.

MDVN January 2015 Options Begin Trading

Medivation (MDVN) Reaches New Lifetime High Today

Two mini flash crashes rock stock market

MDVN January 2017 Options Begin Trading

Should Johnson & Johnson Buy Medivation Inc.?

Johnson & Johnson's top-selling prostate cancer treatment is facing a stiff challenger in Medivation's Xtandi, but an acquisition may not be in the cards.

Dendreon Shares Plummet After It Files for Bankruptcy - Analyst Blog

Update: Medivation Q3 Earnings

The Next Chapter in Dendron's Troubled History: Chapter 11 Bankruptcy

See More Articles...